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Exome Sequencing Identifies an MYH3 Mutation
in a Family with Distal Arthrogryposis Type 1
David M. Alvarado, PhD, Jillian G. Buchan, BS, Christina A. Gurnett, MD, PhD, and Matthew B. Dobbs, MD
Investigation performed at Washington University School of Medicine, St. Louis, Missouri

Background: Few genes responsible for distal arthrogryposis type 1 are known, although genes coding for the proteins in
the sarcomere have been implicated in other types of distal arthrogryposis. Cost-effective sequencing methods are now
available to examine all genes in the human genome for the purpose of establishing the genetic basis of musculoskeletal
disorders.
Methods: A multigenerational family with distal arthrogryposis type 1 characterized by clubfoot and mild hand contractures was identified, and exome sequencing was performed on DNA from one of the affected family members. Linkage
analysis was used to confirm whether a genetic variant segregated with distal arthrogryposis.
Results: Exome sequencing identified 573 novel variants that were not present in control databases. A missense
mutation in MYH3 (a gene coding for the heavy chain of myosin), causing an F437I amino acid substitution, was identified
that segregated with distal arthrogryposis in this family. Linkage analysis confirmed that this MYH3 mutation was the only
exome variant common to all six affected individuals.
Conclusions: Identification of an MYH3 mutation in this family with distal arthrogryposis type 1 broadens the phenotype
associated with MYH3 mutations to include distal arthrogryposis types 1, 2A (Freeman-Sheldon syndrome), and 2B
(Sheldon-Hall syndrome). Exome sequencing is a useful and cost-effective method to discover causative genetic mutations, although data from extended families may be needed to confirm the importance of the hundreds of identified
variants.
Clinical Relevance: Distal arthrogryposis type 1 should be considered in the differential diagnosis of isolated clubfoot,
particularly when hand contractures are present in any family member or when the clubfoot is severe and resistant to
treatment.

D

istal arthrogryposis is characterized by contractures of
the distal regions of the hands and feet1. The severe types
of distal arthrogryposis, types 2A (also called FreemanSheldon syndrome) and 2B (also called Sheldon-Hall syndrome),
include facial involvement and scoliosis, whereas distal arthrogryposis type 1 (DA1) does not2. Distal arthrogryposis type 1 affects approximately one in 10,000 children and represents the
most common type3.
Multiple genes encoding proteins in the sarcomere, including myosin heavy chain 3 (MYH3), myosin heavy chain 8
(MYH8), tropomyosin 2 (TPM2), troponin I2 (TNNI2), troponin T3 (TNNT3), and myosin binding protein C1 (MYBPC1)4-9,

have been implicated in distal arthrogryposis syndromes. Although MYH3 mutations account for nearly all cases of FreemanSheldon syndrome (type 2A) and nearly one-third of all cases of
Sheldon-Hall syndrome (type 2B), to our knowledge MYH3
mutations have not been described in patients with distal arthrogryposis type 14. Previous studies have shown that mutations
in known genes are rare causes of distal arthrogryposis type 19,10;
therefore, genetic heterogeneity is expected and additional causative genes remain to be identified.
Because of the large number of genes as well as the relatively large size of the genes already implicated in distal arthrogryposis syndromes, new methods to sequence all genes are
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necessary to effectively define the genetic basis of distal arthrogryposis in individual families. Exome sequencing is a new
genetic tool that uses next-generation sequencing methods to
identify mutations within the coding exons of the entire human
genome (the ‘‘exome’’)11. Because the exome comprises just 1%
of the genome, the cost of sequencing only the exons is currently
only a fraction of the cost of whole-genome sequencing.
The next-generation exome capture and sequencing methods that were used in this study represent a substantial advance
in research methods and, despite their limitations, these methods
are likely to soon have a major impact on the diagnosis of patients with inherited musculoskeletal disorders. For instance, our
identification of a mutation in MYH3 in the family described in
this study broadens the phenotype associated with MYH3 mutations to include distal arthrogryposis type 1 and suggests that
there may be substantial overlap between types 1, 2A, and 2B.
Distal arthrogryposis type 1 should be considered in the differential diagnosis of isolated clubfoot, particularly in the presence
of even minor hand contractures in the patient or family members.
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unaffected members of a family that included six individuals with distal arthrogryposis type 1. Exome capture was performed for one of the affected
family members (the proband) with use of the SureSelect All Exon 38Mb kit
(Agilent Technologies, Santa Clara, California). The DNA was sequenced on a
single lane of a HiSeq 2000 sequencer (Illumina, San Diego, California). The
sequence was aligned to the hg18 assembly of the genome with use of Novoalign
software (Novocraft Technologies, Selangor, Malaysia), and variants were
12
13
identified with use of SAMtools and SeattleSeq . Only variants with at least
sixfold read coverage and a Phred-scaled single-nucleotide polymorphism
quality of ‡30 were included for further analysis. Variants present in the 1000
Genomes Project (http://www.1000genomes.org), dbSNP (build 129; National
Center for Biotechnology Information, Bethesda, Maryland), or our in-house
exome database of twenty patients with unrelated disorders were removed.
Confirmation of selected variants was performed by means of Sanger sequencing
with use of an ABI 3730 Sequencer (Life Technologies, Carlsbad, California).
Linkage analysis was performed with array genotyping data from six affected and six unaffected family members, assuming 80% penetrance and a 0.1%
frequency of the allele responsible for the disease. The genotyping was performed
with use of a Mapping 10K XbaI array (Affymetrix, Santa Clara, California) by the
National Institutes of Health Neuroscience Microarray Consortium (Los Angeles,
9
California). Linkage analysis was performed as previously described .

Source of Funding
Materials and Methods

T

he study was approved by our institutional review board, and all subjects
gave informed consent. DNA was obtained from all affected and several

Grants from Shriners Hospitals for Children, the Children’s Discovery Institute,
the March of Dimes (Basil O’Connor Starter Scholar Research Award), the
St. Louis Children’s Hospital Foundation, the Pediatric Orthopaedic Society of

Fig. 1

Distal limb contractures in family members with distal arthrogryposis type 1. A: The feet of the proband (identified as III:3 in Fig. 2), showing unilateral
clubfoot of the left foot. B: The feet of the proband after correction of the clubfoot with use of the Ponseti method, showing limited residual deformity at
the age of seven years. C: Proximally placed thumbs and distal interphalangeal joint contractures in an aunt of the proband (identified as II:7 in Fig. 2).
D: Camptodactyly in the father of the proband (identified as II:9 in Fig. 2).
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Fig. 2

Pedigree of the family, showing members with and without distal arthrogryposis type 1. Black shading indicates clubfoot, and asterisks indicate hand
contractures. The presence of the MYH3 F437I mutation is indicated by ‘‘Mut,’’ and its absence is indicated by ‘‘WT.’’
North America, the Orthopaedic Research and Education Foundation, and the
National Institutes of Health were used to fund the basic science experiments.

Results
multigenerational family presented with incompletely
penetrant, autosomal-dominant distal arthrogryposis type
1 characterized by clubfoot and mild hand contractures. Five
family members had clubfoot, which was bilateral in four individuals and unilateral in one (Fig. 1, A). The proband (identified as III:3 in the family pedigree), who had unilateral
clubfoot, had initial correction of the clubfoot with the Ponseti
method14 (Fig. 1, B) but had two relapses and required repeat
Achilles tendon tenotomies to maintain correction. The other
family members with clubfoot had been treated with extensive
soft-tissue releases. Two of the family members with clubfoot
(individuals II:7 and II:9) also had mild hand contractures
predominantly involving the distal interphalangeal joints (Fig.
1, C and D). In addition, one family member (individual II:1)
developed contractures at the distal interphalangeal joints
during adolescence but did not have clubfoot or other lowerextremity involvement. Other signs of hand involvement,
including absent flexion creases, overriding fingers, and proximally placed thumbs, were absent in the proband and the
other individuals who exhibited only clubfoot. Because facial
involvement was absent, a diagnosis of distal arthrogryposis
type 1 was made.

A

Sequencing of myosin binding protein C1 (MYBPC1), a
gene that has recently been implicated in some cases of distal
arthrogryposis type 19, did not reveal any causative mutations.
However, because few genes responsible for distal arthrogryposis type 1 have been identified1,9, we performed exome sequencing of the DNA of the proband on a research basis.
Analysis of a single lane of Illumina HiSeq paired-end
sequence resulted in 142,366,935 reads, of which 93% could
be aligned with the human genome. This provided 93% coverage of the sequence at a minimum sequencing depth of
6·. With this method, a total of 24,323 variants that would
cause nonsynonymous amino acid substitutions, splice-site
variants, insertions, or deletions were identified in the exome
of the proband. After the exclusion of variants that were present at a frequency of >5% in control databases, 524 singlenucleotide variants and forty-nine indels (insertions or deletions)
remained.
One of these 573 variants consisted of a missense mutation in MYH3, the embryonic myosin heavy chain gene that
has previously been implicated in distal arthrogryposis types
2A and 2B4. Sanger sequencing confirmed the presence of the
MYH3 F437I mutation in all of the individuals with clubfoot as
well as in the individual with adolescent-onset hand contractures (Fig. 2). The A/T missense mutation at chr17:10488494
(hg18) results in the substitution of the amino acid isoleucine
for phenylalanine at residue 437. This residue is within the

Fig. 3

Alignment of MYH3 amino acids surrounding the location corresponding to the F437I mutation in sequences from multiple species. The phenylalanine at
residue 437 is indicated by the rectangle and is conserved across all of the species shown, including mouse, rat, human, cow, frog, and chicken. The
sequences were aligned with use of the CLUSTALW program (http://align.genome.jp).
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Fig. 4

Ribbon diagram of the MYH3 S2 (myosin head) region containing amino acids 4
through 1022. The location of the MYH3 F437I mutation identified in the family
with distal arthrogryposis type 1 is shown in orange. The locations of five other
known mutations causing distal arthrogryposis type 2A (Freeman-Sheldon
syndrome) are shown in red; four of these are in the myosin head and lie in the
4

groove that forms the ATP binding site . The image was generated by the SwissPDBViewer (DeepView) program (http://ca.expasy.org/spdbv) for protein
accession number P11055 (MYH3).

myosin head and is highly conserved across multiple species4
(Fig. 3), but it lies outside the ATP binding groove where
mutations appear to cause the most severe form of distal

arthrogryposis, Freeman-Sheldon syndrome (type 2A) (Fig.
4)4. This mutation is predicted with 99.7% confidence by the
PolyPhen-215 program to be ‘‘probably damaging.’’

Fig. 5

Linkage of distal arthrogryposis type 1 to chromosome 17p. A genome-wide profile of parametric multipoint LOD (logarithm of odds) scores for the family with
distal arthrogryposis type 1, constructed from the Affymetrix 10K array data. The human chromosomes, running from the p terminal (left) to the q terminal
(right), are concatenated on the horizontal axis. The vertical axis shows the parametric LOD score for the physical locations on the human chromosome
indicated on the horizontal axis. The peak LOD (pLOD) score (defining the strongest region of linkage) of 1.86 was within chromosome 17p.
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To confirm the importance of this MYH3 F437I mutation, linkage analysis was performed with the use of Affymetrix
10K single-nucleotide polymorphism data from all six affected
individuals in the family. The greatest LOD (logarithm of odds)
score, 1.86, was found on chromosome 17p, which contains the
MYH3 gene (Fig. 5), and the MYH3 mutation was the only
exome variant that was located within the approximately 3-Mb
linkage interval. None of the other, less significant linkage intervals contained any of the other rare variants.
Discussion
ur results demonstrate that MYH3 mutations may be associated with distal arthrogryposis type 1 (as well as with
types 2A and 2B as previously described4). All types of distal
arthrogryposis are characterized by extensive phenotypic variability between and within families1, and our data suggest that
there is also likely to be clinical and genetic overlap of distal
arthrogryposis type 1 with types 2A and 2B. Future classification systems for these syndromes that take into account both
the genotype and the phenotype are needed.
The identification of MYH3 as the location of the diseasecausing mutation in this family with distal arthrogryposis
type 1 is supported by the known association of this gene with
distal arthrogryposis types 2A and 2B, which are disorders
closely related to distal arthrogryposis type 1, and by the prediction that the F437I mutation would be damaging to the function of the protein. Furthermore, the phenylalanine at residue
437 is highly conserved across many mammalian species and
the mutation was not identified in any of the controls. Most
notably, segregation of the MYH3 F437I mutation in all affected family members increased our confidence that we have
correctly identified the disease-causing mutation. The sequencing
of variants in additional family members remains a useful, if
not critical, method to increase the likelihood that a diseasecausing variant has been correctly identified, and this method
should continue to be offered by clinical laboratories.
The location of the MYH3 mutation may correlate with
the severity of distal arthrogryposis, as suggested by Toydemir
et al.4. The consistently mild phenotype of the distal arthrogryposis in all of the affected family members provides further
support for a genotype-phenotype correlation in diseases involving MYH3. The F437I mutation is slightly outside the ATP
binding groove where mutations causing the most severe form of
distal arthrogryposis, Freeman-Sheldon syndrome (type 2A), are
located4. However, understanding the physiological impact of
MYH3 missense mutations that could alter skeletal muscle
contractility (by affecting nucleotide binding, ATP catalysis, or
interaction with actin or regulatory proteins) has been hindered
by the lack of convenient assays. Further studies are needed to
better understand how these mutations cause disease.
The family described in this study also demonstrates the
occasional difficulty of identifying distal arthrogryposis type
1 as the cause of isolated clubfoot. Although three individuals
from this family had isolated clubfoot, the presence of hand
contractures in even one family member should indicate the
possibility of distal arthrogryposis. Nevertheless, hand con-

O
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tractures may not appear until adolescence, as demonstrated in
individual II:1, who had the MYH3 F437I mutation. Although
worsening of contractures may occur if appropriate therapy
such as bracing is not used, contractures are generally thought
to be nonprogressive in cases of distal arthrogryposis16. The
nonprogressive and often congenital nature of contractures in
distal arthrogryposis had been attributed to the location of the
defects in genes such as MYH3 that were believed to be expressed exclusively during fetal development1,16. Recent studies,
however, have shown that MYH3 is also expressed in adult
muscle17, perhaps explaining the late-onset hand contractures
in one member of this family. Distal arthrogryposis should also
be considered in the differential diagnosis for families with
highly penetrant, autosomal-dominant clubfoot, as this inheritance pattern is relatively rare in isolated clubfoot, with the
exception of clubfoot associated with recurrent chromosome
17q23 microdeletions and microduplications that are responsible for approximately 5% of all cases of familial clubfoot18.
Clubfoot that is resistant to treatment should also signal the
possibility of distal arthrogryposis14. Although the proband’s
clubfoot was treated nonsurgically with use of the Ponseti
method14, she developed multiple recurrences. Despite these
complications, excellent outcomes are possible in patients in
whom distal arthrogryposis is treated with use of the Ponseti
method14.
The results of this study demonstrate the power of new
sequencing methods for the diagnosis of human musculoskeletal disease. Although exome sequencing of the patient in this
study was done on a research basis, clinically available diagnostic testing will soon utilize similar methods to screen large
gene panels for mutations related to diseases. Exome analysis is
a reasonable approach for the identification of disease-causing
mutations for several reasons. First, the vast majority of currently identified disease-causing mutations are located within
the coding regions of genes (the exome), although this is likely
to change in the future as researchers are now discovering the
extent to which regions that do not code for proteins can affect
human health and disease19. Second, because the exome comprises only 1% of the genome, the cost of sequencing the exome
is currently a fraction of the cost of whole-genome sequencing.
Finally, analysis of the exome is less complicated than analysis of
the entire genome because of the availability of well-established
methods to predict or experimentally test for the effect of a
mutation on the function of the protein11.
The interpretation of variants in coding exons, while
simpler than the interpretation of the results of whole-genome
sequence analysis, remains complex. Analysis of exome data
relies heavily on the use of filtering methods to exclude variants
that are also present in some healthy (control) individuals.
These normal variants are being compiled through the efforts
of the 1000 Genomes Project, the goal of which is to identify
rare variants in more than 1000 healthy individuals from various populations20. However, such ‘‘control’’ databases are likely
to include disease-causing mutations with low penetrance as
well as mutations causing late-onset disorders that have not yet
manifested in the reportedly normal individuals who provided
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the control samples. Collections of disease-causing variants in
databases such as the Human Gene Mutation Database will
also assist in the analysis of exome sequencing data, but this
database currently lists only thirteen MYH3 mutations21. Because mutations responsible for rare disorders such as distal
arthrogryposis may be found only in single families, such databases may currently be of limited use for exome analysis.
Eventually, however, they may become populated with variants
that are known with high confidence to be associated with
specific diseases. Finally, algorithms are available to predict the
functional effects of gene mutations that modify proteins.
However, many disease-associated mutations, including several previously described mutations in human myosin heavy
chain genes4,22, are incorrectly predicted by programs such as
PolyPhen-2 to be ‘‘benign’’ mutations, thus limiting the overall
usefulness of this type of analysis.
Despite the limitations of exome sequencing, such as the
difficulty of distinguishing the disease-causing variant from the
large number of other novel variants identified, we expect that
these techniques will rapidly advance medical research and
revolutionize patient care. As demonstrated here with MYH3,
disease-associated gene variations are gradually being shown to
be responsible for an expanded range of phenotypes as exome
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sequencing technology identifies mutations that are also found
in patients with related disorders. Although MYH3 mutations
are uncommon causes of isolated clubfoot10,23, the diagnosis
of distal arthrogryposis should be considered when hand
contractures (even those that develop during adolescence) are
present in any family members or when the clubfoot is severe
and resistant to treatment. Although MYH3 sequencing is
currently available as a single-gene genetic test24, we anticipate
that extended gene panels or exome-based sequencing will
soon be available for musculoskeletal disorders such as distal
arthrogryposis. n
NOTE: Exome capture and sequencing was performed by the Washington University Department of
Genetics Genome Technology Access Center (GTAC). The National Institutes of Health Microarray
Consortium performed the Affymetrix microarray analysis.
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